Presented at PVRI's Drug Discovery & Development Symposium 2025, by Luke Howard, Imperial College London

Telehealth utilization increased during the coronavirus disease-2019 (COVID-19) pandemic, which encouraged remote patient management. The identification of optimal strategies to enhance telehealth and address barriers to its use for patients with pulmonary arterial hypertension (PAH) may improve patient outcomes. 

In this Community Call, we discussed:

• Epicardial adipose tissue as an independent risk factor for mortality in pulmonary arterial hypertension
• Morbidity and mortality associated with pulmonary arterial hypertension in a schistosomiasis‐endemic region of Brazil

When performing cardiac catheterization in pediatric outpatients with pulmonary arterial hypertension (PH), our approach is to allow spontaneous ventilation, minimize procedural length, and evaluate for same-day discharge whenever safe and feasible. We describe our experience with this approach and identify clinical characteristics that influenced procedural safety.